98%
921
2 minutes
20
Radix Bupleuri polysaccharides (RBP) are heteropolysaccharides with a molecular weight distribution ranging from 1.10 to 121.21 kDa, extracted from the traditional Chinese medicinal herb Radix Bupleuri. Using DEAE-cellulose column chromatography, one neutral polysaccharide (RBP-1) and two acidic polysaccharides (RBP-2 and RBP-3) were isolated. These polysaccharides exhibited the capability to activate RAW264.7 macrophages, with the acidic fractions demonstrating greater effects than the neutral ones. RNA sequencing revealed that differentially expressed genes (DEGs) were significantly enriched in MAPK and NF-κB signaling pathways following RBP-3 treatment. Mechanistic studies further demonstrated that RBP-3 activates these pathways through toll-like receptors TLR2 and TLR4. Additionally, RBP effectively alleviated immunosuppression by modulating gut microbiota and restoring the integrity of the intestinal mucosal barrier in cyclophosphamide (CTX)-induced immunosuppressed mice. RBP influenced the generation of colonic short-chain fatty acids (SCFAs), regulated CD4+ T cell differentiation, and enhanced intestinal immune function. These findings highlight RBP potential as a natural immunomodulator and establish a theoretical foundation for the formulation of immune-supportive botanical products derived from Radix Bupleuri.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijbiomac.2025.147092 | DOI Listing |
Int J Biol Macromol
August 2025
Dongguan Maternal and Child Health Care Hospital, Postdoctoral Innovation Practice Base of Southern Medical University, Dongguan, Guangdong, 523000, China; State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Me
Radix Bupleuri polysaccharides (RBP) are heteropolysaccharides with a molecular weight distribution ranging from 1.10 to 121.21 kDa, extracted from the traditional Chinese medicinal herb Radix Bupleuri.
View Article and Find Full Text PDFFront Nutr
July 2025
Department of Clinical Nutrition, West China Hospital, Sichuan University, Chengdu, China.
Objectives: Accumulating clinical evidence demonstrates the therapeutic potential of Traditional Chinese Medicine (TCM) in mitigating depressive disorders. This research focuses on quercetin, a principal bioactive constituent shared among five classical TCM antidepressant formulations, to systematically decode its multi-target mechanisms via an integrative framework combining neuroinflammatory modulation and synaptic plasticity regulation.
Methods: A tripartite experimental design was implemented.
Zhongguo Zhen Jiu
July 2025
Department of Orthopedic and Rehabilitation, Cangzhou Hospital of Integrated Chinese and Western Medicine of Hebei Province, Cangzhou 061000, China.
Objective: To observe the clinical effect of acupuncture and moxibustion combined with umbilical therapy on anxiety and depression in patients with neurogenic bladder (NB) after spinal cord injury (SCI).
Methods: Thirty cases of NB after SCI with anxiety and depression were selected and treated with acupuncture and moxibustion combined with umbilical therapy. Acupuncture was applied at Baihui (GV20), Yintang (GV24), Sanyinjiao (SP6), Shenmen (HT7), Hegu (LI4), Taichong (LR3), once a day, continuous treatment for 4 weeks.
Cytotechnology
August 2025
Department of Gastroenterology, Dafeng People's Hospital, Yancheng, 224100 Jiangsu China.
Radix Bupleuri (RB) is used as a traditional Chinese medicine for treating gastric disorders. However, the active components and pharmacological targets of RB are unknown. In this study, we aimed to reveal the pharmacological effects of RB on gastritis by combining a rat model and a network pharmacology approach.
View Article and Find Full Text PDFJ Ethnopharmacol
August 2025
Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Institute of Basic Medicine, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350122, China. Electronic address:
Ethnopharmacological Relevance: Saikosaponin C (SSc), a traditional Chinese herbal medicine, is a triterpene saponin and an active compound extracted from Radix Bupleuri. It has been demonstrated to have neuroprotective effects in cellular models of neurodegenerative diseases; however, its precise mechanism of action in alleviating tau pathology in Alzheimer's disease (AD), as well as its potential to improve cognitive deficits in animal models, has not yet been elucidated.
Aim Of The Study: In this study, we investigated the in vivo therapeutic effects of SSc on a human tau (hTau) mouse model expressing normal hTau isoforms in terms of tau-related pathology (tauopathy) and the underlying mechanisms.